Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SCARB1 | Q8WTV0 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12597391 | 0.92 | ALDH1A1 (0.42) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL1979651 | 0.91 | ALDH1A1 (0.47) | CNR2ALDH1A1MAPK1KDM4ENPC1 | |
| SCHEMBL1978626 | 0.90 | CNR2 (0.62) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL13640281 | 0.89 | CNR2 (0.56) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL18807690 | 0.88 | ALDH1A1 (0.46) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL13640233 | 0.88 | ALDH1A1 (0.39) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL18807691 | 0.87 | ALDH1A1 (0.39) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL12596931 | 0.87 | CNR2 (0.40) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL14212155 | 0.87 | CNR2 (0.45) | CNR2ALDH1A1MAPK1LMNAKDM4E | |
| SCHEMBL1978510 | 0.87 | CNR2 (0.68) | CNR2ALDH1A1KDM4ENPC1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2509948-B1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2017-05-03 | — | — | EP | disclosed |
| EP-2509948-B1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2017-05-03 | — | — | EP | disclosed |
| EP-2510400-B1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2015-04-29 | — | — | EP | disclosed |
| EP-2510400-B1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA GRAPHICS NV (BE) | 2015-04-29 | — | — | EP | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8957224-B2 | Photoinitiators for UV-LED curable compositions and inks | AGFA GRAPHICS NV (BE) | 2015-02-17 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-8569393-B2 | UV-LED curable compositions and inks | AGFA-GEVAERT N.V. (BE) | 2013-10-29 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-12-06 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| US-20120283349-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT N.V. (BE) | 2012-11-08 | — | — | US | disclosed |
| EP-2510400-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | Agfa-Gevaert (BE) | 2012-10-17 | — | — | EP | disclosed |
| EP-2509948-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | Agfa-Gevaert (BE) | 2012-10-17 | — | — | EP | disclosed |
| WO-2011069943-A1 | UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011069947-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011069947-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | AGFA-GEVAERT (BE) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309861-A1 | PHOTOINITIATORS FOR UV-LED CURABLE COMPOSITIONS AND INKS | WEE1, CBX4, USP9X | CNR2 2086/4885ALDH1A1 1029/4885MAPK1 4340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.